To determine whether c-Abl activation is responsible for PARIS-induced PD relevant phenotypes, PARIS Tg mice were fed a diet containing the c-Abl inhibitor nilotinib starting at 3 weeks of age when PARIS induction was initiated (Supplementary Fig. 5C). Here, ABL1 is linked to Parkinson disease.